The elusive and controversial roles of estrogen and progesterone receptors in human endometriosis

American Journal of Translational Research

Volumn 6, Issue 2, 2014, Pages 104-113

  Shao, Ruijin ^a   Cao, Shujun ^b   Wang, Xiaoqin ^a   Feng, Yi ^a,c   Billig, Håkan ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

Endometriosis; Endometrium; Estrogen receptor subtypes; Progesterone receptor isoforms

Indexed keywords

ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; PROGESTERONE RECEPTOR; RECEPTOR SUBTYPE; STEROID HORMONE;

CELL PROLIFERATION; DISEASE COURSE; DNA METHYLATION; ENDOMETRIOSIS; ENDOMETRIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HUMAN; NONHUMAN; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SIGNAL TRANSDUCTION;

EID: 84892970137     PISSN: None     EISSN: 19438141     Source Type: Journal    
DOI: None     Document Type: Review

References (75)

1. Giudice LC. Clinical practice. Endometriosis. N Engl J Med 2010; 362: 2389-2398.
2. Burney RO and Giudice LC. Pathogenesis and pathophysiology of endometriosis. Fertil Steril 2012; 98: 511-519.
3. Macer ML and Taylor HS. Endometriosis and infertility: a review of the pathogenesis and treatment of endometriosis-associated infertility. Obstet Gynecol Clin North Am 2012; 39: 535-549.
4. Young VJ, Brown JK, Saunders PT and Horne AW. The role of the peritoneum in the pathogenesis of endometriosis. Hum Reprod Update 2013; 19: 558-569.
5. Rogers PA, D'Hooghe TM, Fazleabas A, Giudice LC, Montgomery GW, Petraglia F and Taylor RN. Defining future directions for endometriosis research: workshop report from the 2011 World Congress of Endometriosis In Montpellier, France. Reprod Sci 2013; 20: 483-499.
6. Signorile PG and Baldi A. Endometriosis: new concepts in the pathogenesis. Int J Biochem Cell Biol 2010; 42: 778-780.
7. Forte A, Cipollaro M and Galderisi U. Genetic, epigenetic and stem cell alterations in endometriosis: new insights and potential therapeutic perspectives. Clin Sci (Lond) 2014; 126: 123-138.
8. Evers JL, Dunselman GA, Land JA and Bouckaert PX. Is there a solution for recurrent endometriosis? Br J Clin Pract Suppl 1991; 72: 45-50; discussion 51-43.
9. Huhtinen K, Stahle M, Perheentupa A and Poutanen M. Estrogen biosynthesis and signaling in endometriosis. Mol Cell Endocrinol 2012; 358: 146-154.
10. Nisolle M and Donnez J. Peritoneal endometriosis, ovarian endometriosis, and adenomyotic nodules of the rectovaginal septum are three different entities. Fertil Steril 1997; 68: 585-596.
11. Tirado-Gonzalez I, Barrientos G, Tariverdian N, Arck PC, Garcia MG, Klapp BF and Blois SM. Endometriosis research: animal models for the study of a complex disease. J Reprod Immunol 2010; 86: 141-147.
12. Huhtinen K, Desai R, Stahle M, Salminen A, Handelsman DJ, Perheentupa A and Poutanen M. Endometrial and endometriotic concentrations of estrone and estradiol are determined by local metabolism rather than circulating levels. J Clin Endocrinol Metab 2012; 97: 4228-4235.
13. Critchley HO and Saunders PT. Hormone receptor dynamics in a receptive human endometrium. Reprod Sci 2009; 16: 191-199.
14. Tsai MJ and O'Malley BW. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu Rev Biochem 1994; 63: 451-486.
15. Couse JF, Lindzey J, Grandien K, Gustafsson JA and Korach KS. Tissue distribution and quantitative analysis of estrogen receptor-alpha (ERalpha) and estrogen receptor-beta (ERbeta) messenger ribonucleic acid in the wild-type and ERalpha-knockout mouse. Endocrinology 1997; 138: 4613-4621.
16. Leung YK, Mak P, Hassan S and Ho SM. Estrogen receptor (ER)-beta isoforms: a key to understanding ER-beta signaling. Proc Natl Acad Sci U S A 2006; 103: 13162-13167.
17. Shao R, Feng Y, Zou S, Weijdegard B, Wu G, Brannstrom M and Billig H. The role of estrogen in the pathophysiology of tubal ectopic pregnancy. Am J Transl Res 2012; 4: 269-278.
18. Paech K, Webb P, Kuiper GG, Nilsson S, Gustafsson J, Kushner PJ and Scanlan TS. Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. Science 1997; 277: 1508-1510.
19. Pettersson K, Delaunay F and Gustafsson JA. Estrogen receptor beta acts as a dominant regulator of estrogen signaling. Oncogene 2000; 19: 4970-4978.
20. Hall JM and McDonnell DP. The estrogen receptor beta-isoform (ERbeta) of the human estrogen receptor modulates ERalpha transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens. Endocrinology 1999; 140: 5566-5578.
21. Bulun SE, Cheng YH, Pavone ME, Xue Q, Attar E, Trukhacheva E, Tokunaga H, Utsunomiya H, Yin P, Luo X, Lin Z, Imir G, Thung S, Su EJ and Kim JJ. Estrogen receptor-beta, estrogen receptor-alpha, and progesterone resistance in endometriosis. Semin Reprod Med 2010; 28: 36-43.
22. Brandenberger AW, Lebovic DI, Tee MK, Ryan IP, Tseng JF, Jaffe RB and Taylor RN. Oestrogen receptor (ER)-alpha and ER-beta isoforms in normal endometrial and endometriosis-derived stromal cells. Mol Hum Reprod 1999; 5: 651-655.
23. Cavallini A, Resta L, Caringella AM, Dinaro E, Lippolis C and Loverro G. Involvement of estrogen receptor-related receptors in human ovarian endometriosis. Fertil Steril 2011; 96: 102-106.
24. Matsuzaki S, Murakami T, Uehara S, Canis M, Sasano H and Okamura K. Expression of estrogen receptor alpha and beta in peritoneal and ovarian endometriosis. Fertil Steril 2001; 75: 1198-1205.
25. Pellegrini C, Gori I, Achtari C, Hornung D, Chardonnens E, Wunder D, Fiche M and Canny GO. The expression of estrogen receptors as well as GREB1, c-MYC, and cyclin D1, estrogen-regulated genes implicated in proliferation, is increased in peritoneal endometriosis. Fertil Steril 2012; 98: 1200-1208.
26. Smuc T, Pucelj MR, Sinkovec J, Husen B, Thole H and Lanisnik Rizner T. Expression analysis of the genes involved in estradiol and progesterone action in human ovarian endometriosis. Gynecol Endocrinol 2007; 23: 105-111.
27. Xue Q, Lin Z, Cheng YH, Huang CC, Marsh E, Yin P, Milad MP, Confino E, Reierstad S, Innes J and Bulun SE. Promoter methylation regulates estrogen receptor 2 in human endometrium and endometriosis. Biol Reprod 2007; 77: 681-687.
28. Attia GR, Zeitoun K, Edwards D, Johns A, Carr BR and Bulun SE. Progesterone receptor isoform A but not B is expressed in endometriosis. J Clin Endocrinol Metab 2000; 85: 2897-2902.
29. Bergqvist A and Ferno M. Oestrogen and progesterone receptors in endometriotic tissue and endometrium: comparison of different cycle phases and ages. Hum Reprod 1993; 8: 2211-2217.
30. Bergqvist A and Ferno M. Estrogen and progesterone receptors in endometriotic tissue and endometrium: comparison according to localization and recurrence. Fertil Steril 1993; 60: 63-68.
31. Bergqvist A, Ferno M and Skoog L. Quantitative enzyme immunoassay and semiquantitative immunohistochemistry of oestrogen and progesterone receptors in endometriotic tissue and endometrium. J Clin Pathol 1997; 50: 496-500.
32. Bergqvist A, Ljungberg O and Skoog L. Immunohistochemical analysis of oestrogen and progesterone receptors in endometriotic tissue and endometrium. Hum Reprod 1993; 8: 1915-1922.
33. Fujimoto J, Hirose R, Sakaguchi H and Tamaya T. Expression of oestrogen receptor-alpha and-beta in ovarian endometriomata. Mol Hum Reprod 1999; 5: 742-747.
34. Liu AJ, Guan Z, Zhang ZM, Wei LX and Li YL. [Study on expression of estrogen receptor isoforms in eutopic and ectopic endometrium of ovarian endometriosis]. Zhonghua Bing Li Xue Za Zhi 2008; 37: 584-588.
35. Howell RJ, Dowsett M and Edmonds DK. Oestrogen and progesterone receptors in endometriosis: heterogeneity of different sites. Hum Reprod 1994; 9: 1752-1758.
36. Jones RK, Bulmer JN and Searle RF. Immunohistochemical characterization of proliferation, oestrogen receptor and progesterone receptor expression in endometriosis: comparison of eutopic and ectopic endometrium with normal cycling endometrium. Hum Reprod 1995; 10: 3272-3279.
37. Prentice A, Randall BJ, Weddell A, McGill A, Henry L, Horne CH and Thomas EJ. Ovarian steroid receptor expression in endometriosis and in two potential parent epithelia: endometrium and peritoneal mesothelium. Hum Reprod 1992; 7: 1318-1325.
38. Fujishita A, Nakane PK, Koji T, Masuzaki H, Chavez RO, Yamabe T and Ishimaru T. Expression of estrogen and progesterone receptors in endometrium and peritoneal endometriosis: an immunohistochemical and in situ hybridization study. Fertil Steril 1997; 67: 856-864.
39. Bukulmez O, Hardy DB, Carr BR, Word RA and Mendelson CR. Inflammatory status influences aromatase and steroid receptor expression in endometriosis. Endocrinology 2008; 149: 1190-1204.
40. Prossnitz ER and Barton M. The G-protein-coupled estrogen receptor GPER in health and disease. Nat Rev Endocrinol 2011; 7: 715-726.
41. Wetendorf M and DeMayo FJ. The progesterone receptor regulates implantation, decidualization, and glandular development via a complex paracrine signaling network. Mol Cell Endocrinol 2012; 357: 108-118.
42. Al-Sabbagh M, Lam EW and Brosens JJ. Mechanisms of endometrial progesterone resistance. Mol Cell Endocrinol 2012; 358: 208-215.
43. Li X and O'Malley BW. Unfolding the action of progesterone receptors. J Biol Chem 2003; 278: 39261-39264.
44. Graham JD and Clarke CL. Physiological action of progesterone in target tissues. Endocr Rev 1997; 18: 502-519.
45. Kastner P, Krust A, Turcotte B, Stropp U, Tora L, Gronemeyer H and Chambon P. Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. EMBO J 1990; 9: 1603-1614.
46. Leonhardt SA, Altmann M and Edwards DP. Agonist and antagonists induce homodimerization and mixed ligand heterodimerization of human progesterone receptors in vivo by a mammalian two-hybrid assay. Mol Endocrinol 1998; 12: 1914-1930.
47. Mangal RK, Wiehle RD, Poindexter AN 3rd and Weigel NL. Differential expression of uterine progesterone receptor forms A and B during the menstrual cycle. J Steroid Biochem Mol Biol 1997; 63: 195-202.
48. Gellersen B, Fernandes MS and Brosens JJ. Non-genomic progesterone actions in female reproduction. Hum Reprod Update 2009; 15: 119-138.
49. Fernandes MS, Pierron V, Michalovich D, Astle S, Thornton S, Peltoketo H, Lam EW, Gellersen B, Huhtaniemi I, Allen J and Brosens JJ. Regulated expression of putative membrane progestin receptor homologues in human endometrium and gestational tissues. J Endocrinol 2005; 187: 89-101.
50. Bunch K, Tinnemore D, Huff S, Hoffer ZS, Burney RO and Stallings JD. Expression Patterns of Progesterone Receptor Membrane Components 1 and 2 in Endometria From Women With and Without Endometriosis. Reprod Sci 2014; 21: 190-7.
51. Plante BJ, Lessey BA, Taylor RN, Wang W, Bagchi MK, Yuan L, Scotchie J, Fritz MA and Young SL. G protein-coupled estrogen receptor (GPER) expression in normal and abnormal endometrium. Reprod Sci 2012; 19: 684-693.
52. Chrousos GP, MacLusky NJ, Brandon DD, Tomita M, Renquist DM, Loriaux DL and Lipsett MB. Progesterone resistance. Adv Exp Med Biol 1986; 196: 317-328.
53. Bulun SE. Progesterone resistance and endometrial disease. Preface. Semin Reprod Med 2010; 28: 3.
54. Wang L, Feng Y, Zou S, Brannstrom M, He L, Billig H and Shao R. Linking DNA methylation to the onset of human tubal ectopic pregnancy. Am J Transl Res 2013; 5: 116-125.
55. Ghabreau L, Roux JP, Niveleau A, Fontaniere B, Mahe C, Mokni M and Frappart L. Correlation between the DNA global methylation status and progesterone receptor expression in normal endometrium, endometrioid adenocarcinoma and precursors. Virchows Arch 2004; 445: 129-134.
56. Vincent ZL, Farquhar CM, Mitchell MD and Ponnampalam AP. Expression and regulation of DNA methyltransferases in human endometrium. Fertil Steril 2011; 95: 1522-1525, e1521.
57. Yamagata Y, Asada H, Tamura I, Lee L, Maekawa R, Taniguchi K, Taketani T, Matsuoka A, Tamura H and Sugino N. DNA methyltransferase expression in the human endometrium: down-regulation by progesterone and estrogen. Hum Reprod 2009; 24: 1126-1132.
58. Wu Y, Strawn E, Basir Z, Halverson G and Guo SW. Aberrant expression of deoxyribonucleic acid methyltransferases DNMT1, DNMT3A, and DNMT3B in women with endometriosis. Fertil Steril 2007; 87: 24-32.
59. Wu Y, Strawn E, Basir Z, Halverson G and Guo SW. Promoter hypermethylation of progesterone receptor isoform B (PR-B) in endometriosis. Epigenetics 2006; 1: 106-111.
60. Hewitt SC, Harrell JC and Korach KS. Lessons in estrogen biology from knockout and transgenic animals. Annu Rev Physiol 2005; 67: 285-308.
61. Burns KA, Rodriguez KF, Hewitt SC, Janardhan KS, Young SL and Korach KS. Role of estrogen receptor signaling required for endometriosis-like lesion establishment in a mouse model. Endocrinology 2012; 153: 3960-3971.
62. Mulac-Jericevic B and Conneely OM. Reproductive tissue selective actions of progesterone receptors. Reproduction 2004; 128: 139-146.
63. Conneely OM, Mulac-Jericevic B, DeMayo F, Lydon JP and O'Malley BW. Reproductive functions of progesterone receptors. Recent Prog Horm Res 2002; 57: 339-355.
64. Fang Z, Yang S, Lydon JP, DeMayo F, Tamura M, Gurates B and Bulun SE. Intact progesterone receptors are essential to counteract the proliferative effect of estradiol in a genetically engineered mouse model of endometriosis. Fertil Steril 2004; 82: 673-678.
65. Curtis SW, Clark J, Myers P and Korach KS. Disruption of estrogen signaling does not prevent progesterone action in the estrogen receptor alpha knockout mouse uterus. Proc Natl Acad Sci U S A 1999; 96: 3646-3651.
66. Wada-Hiraike O, Hiraike H, Okinaga H, Imamov O, Barros RP, Morani A, Omoto Y, Warner M and Gustafsson JA. Role of estrogen receptor beta in uterine stroma and epithelium: Insights from estrogen receptor beta-/-mice. Proc Natl Acad Sci U S A 2006; 103: 18350-18355.
67. Colette S, Defrere S, Van Kerk O, Van Langendonckt A, Dolmans MM and Donnez J. Differential expression of steroidogenic enzymes according to endometriosis type. Fertil Steril 2013; 100: 1642-1649.
68. Delvoux B, D'Hooghe T, Kyama C, Koskimies P, Hermans RJ, Dunselman GA and Romano A. Inhibition of type 1 17beta-hydroxysteroid-dehydrogenase impairs the synthesis of 17beta-estradiol in endometriosis lesions. J Clin Endocrinol Metab 2014; 99: 276-84.
69. Han SJ, Hawkins SM, Begum K, Jung SY, Kovanci E, Qin J, Lydon JP, DeMayo FJ and O'Malley BW. A new isoform of steroid receptor coactivator-1 is crucial for pathogenic progression of endometriosis. Nat Med 2012; 18: 1102-1111.
70. Sundqvist J, Andersson KL, Scarselli G, Gemzell-Danielsson K and Lalitkumar PG. Expression of adhesion, attachment and invasion markers in eutopic and ectopic endometrium: a link to the aetiology of endometriosis. Hum Reprod 2012; 27: 2737-2746.
71. Yu J, Boicea A, Barrett KL, James CO, Bagchi IC, Bagchi MK, Nezhat C, Sidell N and Taylor RN. Reduced connexin 43 in eutopic endometrium and cultured endometrial stromal cells from subjects with endometriosis. Mol Hum Reprod 2013; [Epub ahead of print].
72. Miller MA, Meyer AS, Beste MT, Lasisi Z, Reddy S, Jeng KW, Chen CH, Han J, Isaacson K, Griffith LG and Lauffenburger DA. ADAM-10 and-17 regulate endometriotic cell migration via concerted ligand and receptor shedding feedback on kinase signaling. Proc Natl Acad Sci U S A 2013; 110: E2074-2083.
73. Gonzalez-Ramos R, Van Langendonckt A, Defrere S, Lousse JC, Colette S, Devoto L and Donnez J. Involvement of the nuclear factor-kappaB pathway in the pathogenesis of endometriosis. Fertil Steril 2010; 94: 1985-1994.
74. Matsuzaki S and Darcha C. Involvement of the Wnt/beta-catenin signaling pathway in the cellular and molecular mechanisms of fibrosis in endometriosis. PLoS One 2013; 8: e76808.
75. Eaton JL, Unno K, Caraveo M, Lu Z and Kim JJ. Increased AKT or MEK1/2 Activity Influences Progesterone Receptor Levels and Localization in Endometriosis. J Clin Endocrinol Metab 2013; 98: E1871-1879.